Location History:
- Petach-Tikvah, IL (2003)
- Petach Tikva, IL (2003)
Company Filing History:
2 out of 832,843 Years Active: 2003
Title: Edgar Gelber: Innovator in Cancer Research
Introduction
Edgar Gelber is a notable inventor based in Petach-Tikvah, IL. He has made significant contributions to the field of cancer research, holding 2 patents that focus on innovative methods to inhibit cancer cell growth.
Latest Patents
One of his latest patents is titled "Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides." This invention provides methods for using antisense ADNF III oligonucleotides to inhibit the growth of pathologically proliferating cells. Additionally, it includes methods and kits for detecting the presence of these cells in human tissues. Another significant patent is "Combination therapy with VIP antagonist," which relates to a pharmaceutical composition that combines a polypeptide antagonist of the vasoactive intestinal polypeptide (VIP) with a chemotherapeutic agent. This patent discloses methods for using this pharmaceutical composition in treatment.
Career Highlights
Throughout his career, Edgar Gelber has focused on developing innovative solutions to combat cancer. His work has been instrumental in advancing the understanding of cancer cell behavior and treatment options.
Collaborations
Edgar has collaborated with notable colleagues, including Illana Gozes and Douglas E Brenneman, to further enhance his research and patent developments.
Conclusion
Edgar Gelber's contributions to cancer research through his patents demonstrate his commitment to innovation in the medical field. His work continues to pave the way for new therapeutic approaches to cancer treatment.